Search by Drug Name or NDC
NDC 63323-0519-10 Heparin Sodium 200 [USP'U]/100mL Details
Heparin Sodium 200 [USP'U]/100mL
Heparin Sodium is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is HEPARIN SODIUM.
MedlinePlus Drug Summary
Heparin is used to prevent blood clots from forming in people who have certain medical conditions or who are undergoing certain medical procedures that increase the chance that clots will form. Heparin is also used to stop the growth of clots that have already formed in the blood vessels, but it cannot be used to decrease the size of clots that have already formed. Heparin is also used in small amounts to prevent blood clots from forming in catheters (small plastic tubes through which medication can be administered or blood drawn) that are left in veins over a period of time. Heparin is in a class of medications called anticoagulants ('blood thinners'). It works by decreasing the clotting ability of the blood.
Related Packages: 63323-0519-10Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Heparin Injection
Product Information
| NDC | 63323-0519 |
|---|---|
| Product ID | 63323-519_6077fbfb-7b91-4cba-aee9-b2e5831b5033 |
| Associated GPIs | 83100020222037 83100020222033 |
| GCN Sequence Number | 064220 |
| GCN Sequence Number Description | heparin sodium,porcine/NS/PF IV SOLN 2K/1000ML INTRAVEN |
| HIC3 | M9K |
| HIC3 Description | HEPARIN AND RELATED PREPARATIONS |
| GCN | 99926 |
| HICL Sequence Number | 033442 |
| HICL Sequence Number Description | HEPARIN SODIUM,PORCINE IN 0.9 % SODIUM CHLORIDE/PF |
| Brand/Generic | Generic |
| Proprietary Name | Heparin Sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Heparin Sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | [USP'U]/100mL |
| Substance Name | HEPARIN SODIUM |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Anti-coagulant [EPC], Heparin [CS], Unfractionated Heparin [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212441 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0519-10 (63323051910)
| NDC Package Code | 63323-519-10 |
|---|---|
| Billing NDC | 63323051910 |
| Package | 12 BAG in 1 CASE (63323-519-10) / 1000 mL in 1 BAG (63323-519-01) |
| Marketing Start Date | 2020-07-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |